D. Lappé

D. Lappé, D. Renlund, E. Hammond, 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes.

H. May, D. Lappé, T. Bair, 2013, Heart rhythm.

Ranolazine Reduces Ventricular Tachycardia Burden and ICD Shocks in Patients with Drug‐Refractory ICD Shocks

H. May, D. Lappé, T. Bair, 2011, Pacing and clinical electrophysiology : PACE.

Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.

B. Horne, D. Lappé, D. Renlund, 2005, The American journal of cardiology.

An institutional discharge medication program reduces future cardiovascular readmissions and mortality: an analysis of 43,841 patients with coronary artery disease

B. Horne, D. Lappé, D. Renlund, 2002 .

Effects of statins on six-month survival and clinical restenosis frequency after coronary stent deployment.

B. Horne, D. Lappé, T. Bair, 2002, The American journal of cardiology.

Risk of nephropathy is not increased by the administration of larger volume of contrast during coronary angiography.

B. Horne, D. Lappé, R. Pearson, 2009, Critical pathways in cardiology.

Practical laboratory-based clinical decision tools and associations with short-term bleeding and mortality outcomes.

B. Horne, H. May, D. Lappé, 2018, Clinica chimica acta; international journal of clinical chemistry.

810-5 Use of either metformin or thiazolidinedione is associated with improved survival among patients with type 2 diabetes from a registry of 16,203 diabetic patients

B. Horne, D. Lappé, D. Renlund, 2004 .

Vitamin D supplementation protects against reductions in plasma 25‐hydroxyvitamin D induced by open‐heart surgery: Assess‐d trial

H. May, D. Lappé, J. Carlquist, 2021, Physiological reports.

Is atrial fibrillation an inflammatory disease reflected by elevated C-reactive protein?

B. Horne, D. Lappé, D. Renlund, 2003 .

Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era.

D. Lappé, Jeffrey L. Anderson, J. Muhlestein, 2018, JCI insight.

with Increased Surgical Re-Exploration for Bleeding Early Postoperative Use of Unfractionated Heparin or Enoxaparin is Associated

B. Horne, D. Lappé, D. Renlund, 2013 .

Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding.

B. Horne, J. Muhlestein, D. Lappé, 2005, The Annals of thoracic surgery.

Volume and the Ever-Increasing Standard of Quality Heart Valve Care.

D. Lappé, B. Whisenant, Edward C Miner, 2019, JACC. Cardiovascular interventions.

SUPPLEMENTING DEFICIENT VITAMIN D LEVELS IS ASSOCIATED WITH REDUCED CARDIOVASCULAR RISK

B. Horne, H. May, D. Lappé, 2010 .

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

H. May, D. Lappé, T. Bair, 2014, JAMA.

Two-dimensional echocardiographic diagnosis of left atrial myxoma.

D. Lappé, J. Weiss, B. Bulkley, 1978, Chest.

Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study

B. Horne, D. Lappé, J. Carlquist, 2006, Journal of Thrombosis and Thrombolysis.

Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.

D. Lappé, D. Renlund, E. Hammond, 1996, Clinical transplantation.

Continuous measurement of tissue blood flow by laser-Doppler spectroscopy.

R L Bowman, G. A. Holloway, D. Lappé, 1977, The American journal of physiology.

More Aggressive Left Atrial Ablation in Elderly Patients does not Increase Procedural Complications and Favorably Impacts Outcomes

H. May, D. Lappé, T. Bair, 2011 .

Long‐Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians

H. May, D. Lappé, T. Bair, 2010, Pacing and clinical electrophysiology : PACE.

Temporary Esophageal Stenting Allows Healing of Esophageal Perforations Following Atrial Fibrillation Ablation Procedures

D. Lappé, Jeffrey L. Anderson, T. Bunch, 2006 .

Herbal and Non-Herbal Supplement Use is Common in Warfarin-Treated Patients and the Majority of These Agents Impact Warfarin Safety and Efficacy

D. Lappé, T. Bunch, J. Day, 2011 .

Intracardiac Ultrasound for Esophageal Anatomic Assessment and Localization During Left Atrial Ablation for Atrial Fibrillation

H. May, D. Lappé, T. Bair, 2013, Journal of cardiovascular electrophysiology.

Isolated Drainage of the Superior Vena Cava into the Left Atrium in a 52-Year-Old Man

D. Lappé, M. Ezekowitz, L. Becker, 1978, Circulation.

Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography.

B. Horne, H. May, D. Lappé, 2008, The American journal of cardiology.

Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures.

D. Lappé, Jeffrey L. Anderson, T. Bunch, 2005, Journal of cardiovascular electrophysiology.

Frequency of helicobacter pylori seropositivity and C-reactive protein increase in atrial fibrillation in patients undergoing coronary angiography.

B. Horne, D. Lappé, Jeffrey L. Anderson, 2008, The American journal of cardiology.

Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

B. Horne, H. May, D. Lappé, 2010, Heart rhythm.

Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score.

H. May, D. Lappé, T. Bair, 2013, Heart rhythm.

Atrial Fibrillation Significantly Increases Total Mortality and Stroke Risk Beyond that Conveyed by the CHADS2 Risk Factors

B. Horne, D. Lappé, T. Bunch, 2009, Pacing and clinical electrophysiology : PACE.

The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints

B. Horne, H. May, Brianna S. Ronnow, 2010, European journal of heart failure.

Frequency of elevation of C-reactive protein in atrial fibrillation.

B. Horne, D. Lappé, T. Bair, 2004, The American journal of cardiology.

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

Warfarin Knowledge in Patients with Atrial Fibrillation: Implications for Safety, Efficacy, and Education Strategies

B. Horne, D. Lappé, Jeffrey L. Anderson, 2010, Cardiology.

Atrial Fibrillation and CHADS2 Risk Factors are Associated with Highly Sensitive C‐Reactive Protein Incrementally and Independently

B. Horne, D. Lappé, T. Bunch, 2009, Pacing and clinical electrophysiology : PACE.

Preoperative Use of Enoxaparin Compared With Unfractionated Heparin Increases the Incidence of Re-Exploration for Postoperative Bleeding After Open-Heart Surgery in Patients Who Present With an Acute Coronary Syndrome: Clinical Investigation and Reports

B. Horne, J. Muhlestein, D. Lappé, 2002, Circulation.

Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population.

B. Horne, H. May, D. Lappé, 2010, The American journal of cardiology.

Free thyroxine within the normal reference range predicts risk of atrial fibrillation

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular electrophysiology.

CHA2DS2-VASc scores and Intermountain Mortality Risk Scores for the joint risk stratification of dementia among patients with atrial fibrillation.

B. Horne, H. May, D. Lappé, 2019, Heart rhythm.

Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences.

B. Horne, H. May, D. Lappé, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30‐day outcomes

J. L. Anderson, B. Horne, H. May, 2016, International journal of laboratory hematology.

Automated Identification and Predictive Tools to Help Identify High-risk Heart Failure Patients

R. Scott Evans, James F. Lloyd, Benjamin D. Horne, 2016, AMIA.

Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease.

B. Horne, D. Lappé, D. Renlund, 2004, Annals of epidemiology.

Clinical Decision Support to Efficiently Identify Patients Eligible for Advanced Heart Failure Therapies.

Jose Benuzillo, Colleen Roberts, R Scott Evans, 2017, Journal of cardiac failure.

Coronary artery plaque volume and obesity in patients with diabetes: the factor-64 study.

H. May, D. Lappé, Jeffrey L. Anderson, 2014, Radiology.

Improvement in the predictive ability of the Intermountain Mortality Risk Score by adding routinely collected laboratory tests such as albumin, bilirubin, and white cell differential count

B. Horne, H. May, Brianna S. Ronnow, 2016, Clinical chemistry and laboratory medicine.

Effect of Pacing‐Induced Tachycardia and Myocardial Ischemia on Ventricular Pressure‐Velocity Relationships in Man

D. Lappé, C. Conti, R. Ross, 1972, Circulation.

Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients.

Benjamin D. Horne, Colleen Roberts, Joseph B. Muhlestein, 2008, Journal of cardiac failure.

trial fibrillation is independently associated with senile , ascular , and Alzheimer ’ s dementia

H. May, D. Lappé, Jeffrey L. Anderson, 2022 .

Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System.

H. May, D. Lappé, J. Carlquist, 2016, The American journal of cardiology.

Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population.

W. Kraus, B. Horne, H. May, 2011, Clinica chimica acta; international journal of clinical chemistry.

Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery.

Diane Marshall, D. Lappé, T. French, 2008, Journal of diabetes and its complications.

The association of depression at any time to the risk of death following coronary artery disease diagnosis

B. Horne, H. May, D. Lappé, 2017, European heart journal. Quality of care & clinical outcomes.

Real-world clinical burden and economic assessment associated with hyperkalaemia in a large integrated healthcare system: a retrospective analysis

H. May, D. Lappé, T. Bair, 2021, BMC Primary Care.

Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?

B. Horne, D. Lappé, J. Carlquist, 2004, Cardiology.

Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy.

B. Horne, H. May, D. Lappé, 2011, Heart rhythm.

Diastolic scattered light fluctuation, resting force and twitch force in mammalian cardiac muscle

D. Lappé, E. Lakatta, E. Lakatta, 1981, The Journal of physiology.

Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing.

B. Horne, D. Lappé, Jeffrey L. Anderson, 2019, The American journal of cardiology.

Genome-Wide Significance and Replication of the Chromosome 12p11.22 Locus Near the PTHLH Gene for Peripartum Cardiomyopathy

B. Horne, H. May, J. Muhlestein, 2011, Circulation. Cardiovascular genetics.

Behavioral Nudges as Patient Decision Support for Medication Adherence: The ENCOURAGE Randomized Controlled Trial.

B. Horne, H. May, D. Lappé, 2021, American heart journal.

Partners in Healing: Redesign and expansion of family involvement in inpatient nursing care.

Jorie M. Butler, Samuel M. Brown, D. Lappé, 2021, Nursing.

Predictors of Statin Intolerance in Patients with a New Diagnosis of Atherosclerotic Cardiovascular Disease Within a Large Integrated Healthcare Institution: The IMPRES Study.

H. May, D. Lappé, T. Bair, 2020, Journal of cardiovascular pharmacology.

Absence of Coronary Artery Calcium During Positron Emission Tomography Stress Testing in Patients Without Known Coronary Artery Disease Identifies Individuals With Very Low Risk of Cardiac Events

B. Horne, D. Lappé, Jeffrey L. Anderson, 2020, Circulation. Cardiovascular imaging.

Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.

H. May, D. Lappé, T. Bair, 2018, Journal of clinical lipidology.

Repeated Measurement of the Intermountain Risk Score Enhances Prognostication for Mortality

Benjamin D. Horne, Donald L. Lappé, Deborah Budge, 2013, PloS one.

Partners in Healing: Postsurgical Outcomes After Family Involvement in Nursing Care.

Jorie M. Butler, Samuel M. Brown, D. Lappé, 2018, Chest.

Frequency and clinical impact of hyperkalaemia within a large, modern, real‐world heart failure population

H. May, D. Lappé, T. Bair, 2020, ESC heart failure.

Genome-wide Significance and Replication of the Chromosome 12 p 11 . 22 Locus Near the PTHLH Gene for Peripartum Cardiomyopathy Running title : Horne et al . ; Chromosome 12 p 11 . 22 for Peripartum Cardiomyopathy

B. Horne, H. May, J. Muhlestein, 2011 .

Fasting and other health influences.

B. Horne, H. May, D. Lappé, 2009, The American journal of cardiology.

Improving CHA2DS2-VASc stratification of non-fatal stroke and mortality risk using the Intermountain Mortality Risk Score among patients with atrial fibrillation

B. Horne, H. May, D. Lappé, 2018, Open Heart.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe

D. Lappé, Jeffrey L. Anderson, T. Bunch, 2017, Journal of cardiovascular electrophysiology.

Comparison of effects of high (80 mg) versus low (20 mg) dose of simvastatin on C-reactive protein and lipoproteins in patients with angiographic evidence of coronary arterial narrowing.

B. Horne, D. Lappé, R. Pearson, 2007, The American journal of cardiology.

Abstract 11700: Higher Plasma EPA, EPA/AA and DHA Levels Are Associated With Lower Incident MACE Both in Those With and Without Angiographic CAD

B. Horne, D. Lappé, T. Bair, 2019 .

Right-to-left shunt through patent foramen ovale complicating right ventricular infarction. Successful percutaneous catheter closure.

D. Lappé, S. Krueger, 1988, Chest.

The intermountain risk score predicts incremental age-specific long-term survival and life expectancy.

Deborah Budge, Rami Alharethi, B. Horne, 2011, Translational research : the journal of laboratory and clinical medicine.

Intensity fluctuation spectroscopy monitors contractile activation in "resting" cardiac muscle

D. Lappé, E. Lakatta, 1980, Science.

Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial.

H. May, D. Lappé, T. Bair, 2014, JAMA.

Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

B. Horne, H. May, D. Lappé, 2011, American heart journal.

Extreme erythrocyte macrocytic and microcytic percentages are highly predictive of morbidity and mortality.

B. Horne, H. May, J. Muhlestein, 2018, JCI insight.

Warfarin Is Not Needed in Low‐Risk Patients Following Atrial Fibrillation Ablation Procedures

H. May, D. Lappé, T. Bair, 2009, Journal of cardiovascular electrophysiology.

B. Horne, H. May, D. Lappé, 2007, Circulation.